New Pricing Agreement On Single-Pill HIV Medication To Expand Access To Treatment In LMICs
Devex: Health organizations partner for ‘milestone’ pricing agreement on superior HIV drug
“A new pricing agreement for HIV drugs could represent an ‘unprecedented’ step toward making superior medications available faster and at a large scale in low- and middle-income countries. … The pricing agreement is the result of a coordinated effort by pharmaceutical manufacturers, United Nations agencies, NGOs, and national governments…” (Igoe, 9/22).
Science: New single-day pill for HIV treatment promises more bang for less buck
“For about $75, the governments in South Africa and Kenya will soon be able to treat an HIV-infected person for one year with a pill taken once a day that contains a ‘best-in-class’ combination of three antiretroviral (ARV) drugs. … The annual per-person cost of the new pill, made by generic manufacturers, is also about $25 less than the least expensive similar triple-ARV combo pill on the market…” (Cohen, 9/21).
U.N. News Centre: U.N. hails landmark pricing deal for faster rollout of ‘game-changing’ HIV treatment
“… ‘What we are talking about today with this life-changing announcement is about the quality of medicine, is about equity, is about the dignity, is about access to medicine as a human right,’ Michel Sidibé, executive director of the Joint U.N. Programme on HIV/AIDS (UNAIDS), told a press conference at U.N. Headquarters…” (9/21).
VOA News: UNAIDS Calls for ‘Fast-Track’ Approach to Curbing Epidemic
“…The reduced-price AIDS drugs will be available for purchase by public sector organizations next year, and estimates show the partnership likely will save more than $1 billion in medical costs over the next six years…” (9/22).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.